Zimmer Biomet Holdings ZBH Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Hips | $524.1M-5.6% | $555.4M+9.7% | $506.2M-5.6% | $536.1M+8.1% | $495.8M-4.7% | |
| Knees | $828.6M-9.1% | $911.1M+15.0% | $792.4M-4.1% | $826M+4.2% | $792.9M-5.5% | |
| SET | $562.2M-4.3% | $587.6M+8.5% | $541.5M-1.7% | $550.6M+17.0% | $470.5M-3.8% | |
| Technology And Data Bone Cement And Surgical | $171.8M-9.4% | $189.7M+17.6% | $161.3M-2.0% | $164.6M+9.8% | $149.9M-14.2% | |
| Revenue by Geography | ||||||
| Americas | $1.32B-6.3% | $1.41B+12.7% | $1.25B-1.6% | $1.27B+5.5% | $1.21B-5.2% | |
| Asia Pacific | $272.3M-17.3% | $329.4M-0.5% | $330.9M-1.5% | $336.1M+29.0% | $260.5M-16.6% | |
| EMEA | $489.9M-2.3% | $501.3M+20.2% | $417M-10.8% | $467.5M+5.8% | $441.7M+0.9% | |
| US | $1.21B-7.9% | $1.31B+12.8% | $1.16B-0.8% | $1.17B+5.4% | $1.11B-5.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Zimmer Biomet Holdings break its business down?
- Zimmer Biomet Holdings (ZBH) reports revenue by product across 4 parts — Hips, Knees, SET and Technology And Data Bone Cement And Surgical. Each is extracted from the segment footnotes and tracked over time.
- Where does Zimmer Biomet Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Zimmer Biomet Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
